Top

Published in:

01-04-2012 | Nephrology – Original Paper

Peritoneal dialysis-related infections recommendations: 2010 update. What is new?

Authors: Olga Nikitidou, Vassilios Liakopoulos, Triantafillia Kiparissi, Maria Divani, Konstantinos Leivaditis, Nicholas Dombros

Published in: International Urology and Nephrology | Issue 2/2012

Abstract

The International Society of Peritoneal Dialysis (ISPD) 2010 guidelines on PD-related infections reflect the bulk of knowledge acquired over the last 5 years. It includes new information about causative agents of peritonitis, isolation techniques, or therapeutic regimens. Monitoring of infection rates by reporting of peritonitis and exit site infections, isolated microorganism, and presumed etiology is recommended. Furthermore, special focus is given on careful evaluation of each episode of peritonitis in order to determine the route of infection and to reassess patient’s training. In this article, we record the changes in the last ISPD (2010) guidelines compared to the previous ones published in March 2005.

Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG (2010) Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30(4):393–423PubMedCrossRef

Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F, Uttley L (2005) Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 25(2):107–131PubMed

Kwan TH, Tong MK, Siu YP, Leung KT, Luk SH, Cheung YK (2004) Ultrasonography in the management of exit site infections in peritoneal dialysis patients. Nephrology (Carlton) 9(6):348–352CrossRef

Cervelli M (2007) The renal drug reference guide. Kidney Health Australia, Adelaide

Lui SL, Yip T, Tse KC, Lam MF, Lai KN, Lo WK (2005) Treatment of refractory Pseudomonas aeruginosa exit-site infection by simultaneous removal and reinsertion of peritoneal dialysis catheter. Perit Dial Int 25(6):560–563PubMed

Azap OK, Timurkaynak F, Sezer S, Cagir U, Yapar G, Arslan H, Ozdemir N (2006) Value of automatized blood culture systems in the diagnosis of continuous ambulatory peritoneal dialysis peritonitis. Transplant Proc 38(2):411–412PubMedCrossRef

Chow KM, Chow VC, Szeto CC, Law MC, Leung CB, Li PK (2007) Continuous ambulatory peritoneal dialysis peritonitis: broth inoculation culture versus water lysis method. Nephron Clin Pract 105(3):c121–c125PubMedCrossRef

Park SJ, Lee JY, Tak WT, Lee JH (2005) Using reagent strips for rapid diagnosis of peritonitis in peritoneal dialysis patients. Adv Perit Dial 21:69–71PubMed

Akman S, Uygun V, Guven AG (2005) Value of the urine strip test in the early diagnosis of bacterial peritonitis. Pediatr Int 47(5):523–527PubMedCrossRef

10.

Nguyen-Khac E, Cadranel JF, Thevenot T, Nousbaum JB (2008) Review article: the utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients. Aliment Pharmacol Ther 28(3):282–288PubMedCrossRef

11.

Ro Y, Hamada C, Io H, Hayashi K, Hirahara I, Tomino Y (2004) Rapid, simple, and reliable method for the diagnosis of CAPD peritonitis using the new MMP-9 test kit. J Clin Lab Anal 18(4):224–230PubMedCrossRef

12.

Ota K, Maruyama H, Iino N, Nakamura G, Shimotori M, Tanabe Y, Tsukada H, Gejyo F (2007) Rapid detection of causative pathogen of peritonitis using in situ hybridization in a patient with continuous ambulatory peritoneal dialysis. J Infect Chemother 13(4):273–275PubMedCrossRef

13.

Yoo TH, Chang KH, Ryu DR, Kim JS, Choi HY, Park HC, Kang SW, Choi KH, Kim JM, Ha SK, Han DS, Lee HY (2006) Usefulness of 23S rRNA amplification by PCR in the detection of bacteria in CAPD peritonitis. Am J Nephrol 26(2):115–120PubMedCrossRef

14.

Johnson G, Wilks M, Warwick S, Millar MR, Fan SL (2006) Comparative study of diagnosis of PD peritonitis by quantitative polymerase chain reaction for bacterial DNA vs culture methods. J Nephrol 19(1):45–49PubMed

15.

Lui SL, Cheng SW, Ng F, Ng SY, Wan KM, Yip T, Tse KC, Lam MF, Lai KN, Lo WK (2005) Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function. Kidney Int 68(5):2375–2380PubMedCrossRef

16.

Goffin E, Herbiet L, Pouthier D, Pochet JM, Lafontaine JJ, Christophe JL, Gigi J, Vandercam B (2004) Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis-associated peritonitis. Perit Dial Int 24(5):433–439PubMed

17.

Lima RC, Barreira A, Cardoso FL, Lima MH, Leite M Jr (2007) Ciprofloxacin and cefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis: five-year follow-up. Perit Dial Int 27(1):56–60PubMed

18.

Kobayashi K, Nakamoto H, Okada S, Hoshitani K, Uchida K, Arima H, Shoda J, Takane Y, Ikeda N, Sugahara S, Okada H, Suzuki H (2006) Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial 22:65–68PubMed

19.

Livermore DM (2009) Has the era of untreatable infections arrived? J Antimicrob Chemother 64(Suppl 1):i29–i36PubMedCrossRef

20.

Blunden M, Zeitlin D, Ashman N, Fan SL (2007) Single UK centre experience on the treatment of PD peritonitis–antibiotic levels and outcomes. Nephrol Dial Transplant 22(6):1714–1719PubMedCrossRef

21.

Tong MK, Leung KT, Siu YP, Lee KF, Lee HK, Yung CY, Kwan TH, Au TC (2005) Use of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis. J Nephrol 18(2):204–208PubMed

22.

Gadallah MF, Tamayo A, Sandborn M, Ramdeen G, Moles K (2000) Role of intraperitoneal urokinase in acute peritonitis and prevention of catheter loss in peritoneal dialysis patients. Adv Perit Dial 16:233–236PubMed

23.

Innes A, Burden RP, Finch RG, Morgan AG (1994) Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double-blind clinical trial. Nephrol Dial Transplant 9(7):797–799PubMed

24.

Williams AJ, Boletis I, Johnson BF, Raftery AT, Cohen GL, Moorhead PJ, el Nahas AM, Brown CB (1989) Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis. Perit Dial Int 9(1):65–67PubMed

25.

Coban E, Ozdogan M, Tuncer M, Bozcuk H, Ersoy F (2004) The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis. J Nephrol 17(3):427–430PubMed

26.

Wong PN, Lo KY, Tong GM, Chan SF, Lo MW, Mak SK, Wong AK (2007) Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit Dial Int 27(5):531–536PubMed

27.

Liakopoulos V, Stefanidis I, Dombros NV (2010) Peritoneal dialysis glossary 2009. Int Urol Nephrol 42(2):417–423PubMedCrossRef

28.

Szeto CC, Kwan BC, Chow KM, Law MC, Pang WF, Chung KY, Leung CB, Li PK (2009) Recurrent and relapsing peritonitis: causative organisms and response to treatment. Am J Kidney Dis 54(4):702–710PubMedCrossRef

29.

Chow KM, Szeto CC, Cheung KK, Leung CB, Wong SS, Law MC, Ho YW, Li PK (2006) Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis. Clin J Am Soc Nephrol 1(4):768–773PubMedCrossRef

30.

Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, Raoult D (2009) Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 49(4):543–551PubMedCrossRef

31.

van Veen SQ, Claas EC, Kuijper EJ (2010) High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol 48(3):900–907PubMedCrossRef

32.

Dupont C, Sivadon-Tardy V, Bille E, Dauphin B, Beretti JL, Alvarez AS, Degand N, Ferroni A, Rottman M, Herrmann JL, Nassif X, Ronco E, Carbonnelle E (2010) Identification of clinical coagulase-negative staphylococci, isolated in microbiology laboratories, by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and two automated systems. Clin Microbiol Infect 16(7):998–1004PubMed

33.

Liakopoulos V, Petinaki E, Efthimiadi G, Klapsa D, Giannopoulou M, Dovas S, Eleftheriadis T, Mertens PR, Stefanidis I (2008) Clonal relatedness of methicillin-resistant coagulase-negative staphylococci in the haemodialysis unit of a single university centre in Greece. Nephrol Dial Transplant 23(8):2599–2603PubMedCrossRef

34.

Shukla A, Abreu Z, Bargman JM (2006) Streptococcal PD peritonitis–a 10-year review of one centre’s experience. Nephrol Dial Transplant 21(12):3545–3549PubMedCrossRef

35.

Edey M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2010) Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Nephrol Dial Transplant 25(4):1272–1278PubMedCrossRef

36.

Huen SC, Hall I, Topal J, Mahnensmith RL, Brewster UC, Abu-Alfa AK (2009) Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis. Am J Kidney Dis 54(3):538–541PubMedCrossRef

37.

Szeto CC, Chow KM, Kwan BC, Law MC, Chung KY, Yu S, Leung CB, Li PK (2007) Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases. Clin J Am Soc Nephrol 2(2):245–251PubMedCrossRef

38.

Govindarajulu S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2010) Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int 30(3):311–319PubMedCrossRef

39.

Szeto CC, Chow KM, Chung KY, Kwan BC, Leung CB, Li PK (2005) The clinical course of peritoneal dialysis-related peritonitis caused by Corynebacterium species. Nephrol Dial Transplant 20(12):2793–2796PubMedCrossRef

40.

Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2009) Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant 24(12):3834–3839PubMedCrossRef

41.

Siva B, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2009) Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin J Am Soc Nephrol 4(5):957–964PubMedCrossRef

42.

Zurowska A, Feneberg R, Warady BA, Zimmering M, Monteverde M, Testa S, Calyskan S, Drozdz D, Salusky I, Kemper MJ, Ekim M, Verrina E, Misselwitz J, Schaefer F (2008) Gram-negative peritonitis in children undergoing long-term peritoneal dialysis. Am J Kidney Dis 51(3):455–462PubMedCrossRef

43.

Szeto CC, Chow VC, Chow KM, Lai RW, Chung KY, Leung CB, Kwan BC, Li PK (2006) Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases. Kidney Int 69(7):1245–1252PubMedCrossRef

44.

Szeto CC, Li PK, Leung CB, Yu AW, Lui SF, Lai KN (1997) Xanthomonas maltophilia peritonitis in uremic patients receiving continuous ambulatory peritoneal dialysis. Am J Kidney Dis 29(1):91–95PubMedCrossRef

45.

Tzanetou K, Triantaphillis G, Tsoutsos D, Petropoulou D, Ganteris G, Malamou-Lada E, Ziroyiannis P (2004) Stenotrophomonas maltophilia peritonitis in CAPD patients: susceptibility to antibiotics and treatment outcome: a report of five cases. Perit Dial Int 24(4):401–404PubMed

46.

Liakopoulos V, Arampatzis S, Kourti P, Tsolkas T, Zarogiannis S, Eleftheriadis T, Giannopoulou M, Stefanidis I (2011) Aeromonas hydrophila as a causative organism in peritoneal dialysis-related peritonitis: case report and review of the literature. Clin Nephrol 75(S1):65–68PubMed

47.

Sahin I, Barut HS (2010) Quinolone-resistant Aeromonas hydrophila peritonitis in a CAPD patient. Clin Nephrol 73(3):241–243PubMed

48.

Faber MD, Yee J (2006) Diagnosis and management of enteric disease and abdominal catastrophe in peritoneal dialysis patients with peritonitis. Adv Chronic Kidney Dis 13(3):271–279PubMedCrossRef

49.

Miles R, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW (2009) Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 76(6):622–628PubMedCrossRef

50.

Vargemezis V, Passadakis P, Liakopoulos V, Kriki P, Kantartzi A (2004) Fungal colonization of peritoneal catheter with persistently sterile cloudy effluent, in the absence of clinical findings of fungal peritonitis. Perit Dial Int 24(1):81–84PubMed

51.

Unal A, Kocyigit I, Sipahioglu MH, Tokgoz B, Oymak O, Utas C (2011) Fungal peritonitis in peritoneal dialysis: an analysis of 21 cases. Int Urol Nephrol 43(1):211–213PubMedCrossRef

52.

Madariaga MG, Tenorio A, Proia L (2003) Trichosporon inkin peritonitis treated with caspofungin. J Clin Microbiol 41(12):5827–5829PubMedCrossRef

53.

Matuszkiewicz-Rowinska J (2009) Update on fungal peritonitis and its treatment. Perit Dial Int 29(Suppl 2):S161–S165PubMed

54.

Fourtounas C, Marangos M, Kalliakmani P, Savidaki E, Goumenos DS, Vlachojannis JG (2006) Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy. Nephrol Dial Transplant 21(1):236–237PubMedCrossRef

55.

Sedlacek M, Cotter JG, Suriawinata AA, Kaneko TM, Zuckerman RA, Parsonnet J, Block CA (2008) Mucormycosis peritonitis: more than 2 years of disease-free follow-up after posaconazole salvage therapy after failure of liposomal amphotericin B. Am J Kidney Dis 51(2):302–306PubMedCrossRef

56.

Ghebremedhin B, Bluemel A, Neumann KH, Koenig B, Koenig W (2009) Peritonitis due to Neosartorya pseudofischeri in an elderly patient undergoing peritoneal dialysis successfully treated with voriconazole. J Med Microbiol 58(Pt 5):678–682PubMedCrossRef

57.

Gallieni M, Chiarelli G, Olivi L, Cozzolino M, Cusi D (2011) Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis. Clin Nephrol 75(1):70–73PubMed

58.

Akpolat T (2009) Tuberculous peritonitis. Perit Dial Int 29(Suppl 2):S166–S169PubMed

59.

Tse KC, Lui SL, Cheng VC, Yip TP, Lo WK (2007) A cluster of rapidly growing mycobacterial peritoneal dialysis catheter exit-site infections. Am J Kidney Dis 50(1):e1–e5PubMedCrossRef

Title: Peritoneal dialysis-related infections recommendations: 2010 update. What is new?
Authors: Olga Nikitidou
Vassilios Liakopoulos
Triantafillia Kiparissi
Maria Divani
Konstantinos Leivaditis
Nicholas Dombros
Publication date: 01-04-2012
Publisher: Springer Netherlands
Published in: International Urology and Nephrology / Issue 2/2012
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-011-9995-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2012

Concomitant vesicoureteral reflux and gastroesophageal reflux: an analytic cross-sectional study

Current chemotherapeutic strategies against bladder cancer

Solifenacin objectively decreases urinary sensation in women with overactive bladder syndrome

The association between thyroid hormones and arterial stiffness in peritoneal dialysis patients

Efficacy and safety of desmopressin for treatment of nocturia: a systematic review and meta-analysis of double-blinded trials

Comparison of maximal and more maximal intermittent androgen blockade during 5-year treatment of advanced prostate cancer T3NxMx-1

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials